Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
NCT ID: NCT04159727
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2019-03-28
2020-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Bacterial translocation from gut to blood has been reported.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410
Brain-Gut-Microbiota Interaction in IBS
NCT04296552
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973
Gut Microbiome in Inflammatory Bowel Disease
NCT03589183
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
NCT06471894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IBD or PD patients
20 patients suffering from IBD 10 patients suffering from PD
stool and blood analysis
High throughput sequencing and quantitative PCR
Asymptomatic subjects
30 asymptomatic subjects matched to patients on age, sexe and BMI
stool and blood analysis
High throughput sequencing and quantitative PCR
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stool and blood analysis
High throughput sequencing and quantitative PCR
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* asymptomatic subjects : no chronic disease
* asymptomatic subjects : no treatment
Exclusion Criteria
* people who don't read french
* pregnant women
* people treated by antibiotic, probiotic or prebiotic during the 2 month before inclusion
* people with any diagnosed or treated pathology
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital Européen Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe HALFON, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Européen Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European Hospital
Marseille, Bouches-du Rhone, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.